Has Chandra Rednam received payments from drug or device companies?

Yes. Drug and device makers reported $52,559 in general payments to Chandra Rednam across 209 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chandra Rednam did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chandra Rednam come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chandra Rednam

Internal Medicine · Princeton, NJNPI 1952656878

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (57.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 38.8% of the total. Reporting peaked in 2023 at $28,989 and has fallen 99.8% since, to $60 in 2025. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,559in general payments, 2019–2025

Across 209 payments — averaging $251.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$20K
Abbott$19K
Biotronik Inc.$8K
Boston Scientific$5K
Pfizer$125
AstraZeneca$77
plus $182 from 4 others

What the payments were for

Grants$30,00057%
Travel & lodging$13,65226%
Food & beverage$7,54614%
Education$1,3623%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	62	$20,407
Abbott	35	$18,796
Biotronik Inc.	70	$8,105
Boston Scientific	28	$4,869
Pfizer	1	$125
AstraZeneca	4	$77
E.r. Squibb & Sons, L.L.C.	3	$51
Exact Sciences	3	$47
Sanofi-aventis U.S. LLC	2	$45
Inari Medical, Inc.	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,559 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	29	$119

Paid to pharmacies, not to this prescriber.

Other internal medicine in Princeton

David ShulkinMorristown$1.7M
Howard UdermanLakewood$955K
Darshi SunderamEast Orange$530K
Annika DrongeEmerson$401K
Stephen MarcellaNew Brunswick$331K
Viju VijaysadanKinnelon$325K
Mark MonaneWoodcliff Lake$268K
Martin BedigianLivingston$240K
Rameck HuntPlainsboro$217K
Angel LazoSecaucus$195K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →